ABOUT THE COMPANY

Biocamp. In favor of
life, naturally.


Experience, qualification, competence, development and safety. Combined to research, develop and deliver the best solutions in probiotics and vaccines for poultry production. This is what Biocamp is offering to its customers since it was founded in 1999.

The company is presently active in the national and international poultry market, and is growing as a result of its permanent search for excellence in its products, as well as investments in research and development.

The company has the structure and specialists to strictly follow the standards established in the Good Manufacturing Practices (GMP) certification, as well as the guidelines of the Ministry of Agriculture, Livestock and Food Supply (MAPA) and regulatory agencies. And also, to provide an exclusive and specialized customer service from the very beginning, the first contact, then the sale, delivery and post-sales.

Why be a Biocamp partner
We have the most complete probiotics portfolio of the market and vaccines for commercial layers
We provide technical information for each business model
We offer natural solutions that meet the standards of regulatory agencies and the market requirements
customers has our full attention during the whole process

Our professional team is highly qualified and trained
Our specialized technical support is provided by veterinarians
Quality control of the production process is very strict, establishing the highest control standard and safety tests
The results of our solutions are validated by research institutes and companies that use our\ products
TIMELINE
  • CBM, A VACCINE COMPANY, WAS ESTABLISHED, THE FIRST OF THE BIOCAMP FOUNDERS.

  • CBM IS SOLD TO MALLINCKRODT (NOW CALLED MSD)

  • 1999 EN

    BIOCAMP IS BORN: REGISTRATION AND PRODUCTION OF ADDITIVES FOR ANIMAL FEEDING – PROBIOTICS FROM NORMAL AVIAN GUT FLORA (NAGF)

  • 2002 EN

    CNN, A VACCINE COMPANY, IS ESTABLISHED BY BIOCAMP FOUNDERS

  • 2005 EN

    CNN IS SOLD TO CEVA SANTÉ ANIMAL

  • 2009 EN

    THE PLANT FOR PRODUCTION OF BIOCAMP BIOLOGICALS IS BUILT

  • 2010 EN

    PROBIOTICS START TO BE EXPORTED

  • 2011 EN

    REGISTRATION FOR BIOLOGICALS PRODUCTION IS OBTAINED

  • 2013 EN

    THE CAMPVAC® SG9R LIQUID VACCINE IS LAUNCHED

    PROBIOTICS COLOSTRUM® BIO 21 MIX AND COLOSTRUM® BIO 21 LIQUID ARE PRODUCED

  • 2014 EN

    RESEARCH ON LIVE AND INACTIVATED SALMONELA PARATYPHOID VACCINES IS STARTED

  • 2015 EN

    FREEZE DRIED CAMPVAC® SG9R AND FREEZE DRIED CAMPVAC® MG F ARE LAUNCHED

    A NEW AREA IS ACQUIRED TO PROVIDE PHYSICAL SEPARATION BETWEEN THE MANUFACTURING AND ADMINISTRATIVE PLANTS

    THE NEW STRUCTURE FOR QUALITY CONTROL OF “IN VIVO” TESTS, BIOLOGICAL ASSAYS LABORATORY (LEBB), IS INAUGURATED

  • 2016 EN

    RESEARCH ON PROBIOTICS FOR SWINE AND AQUACULTURE ARE INITIATED

  • 2017 EN

    RESEARCH ON PROBIOTICS FOR AQUACULTURE IS INCREASED

  • 2018 EN

    RESTRUCTURING OF THE PROBIOTICS PLANT WITH INVESTMENTS IN A STRUCTURE WITH LEADING EDGE TECHNOLOGY

    A NEW AREA IS ACQUIRED TO EXPAND THE MANUFACTURING PLANT

  • 2019 EN

    20 YEARS

    THE BIOLOGICAL PRODUCTION AREA IS EXPANDED

    NEW RESEARCH & DEVELOPMENT CENTER